Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ephedrine supplements lack "significant" abuse, should not be controlled -- coalition.

This article was originally published in The Tan Sheet

Executive Summary

EPHEDRINE-CONTAINING SUPPLEMENT ABUSE REJECTED BY INDUSTRY COALITION as a reason to assign controlled substance status to the OTC drug and dietary supplement ingredient. In April 17 comments to FDA on the World Health Organization's potential rescheduling of ephedrine, the Dietary Supplement Safety and Science Coalition (DSSSC) stresses the history of use and safety of the ingredient, stating "ephedrine is not a controlled substance in the U.S. today, nor should it be internationally."
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS088413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel